Divis Laboratories Ltd | DIVI - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Alaunos Therapeutics USD 354K 1.03M 2026-03
Aurobindo Pharma INR 88.91B 6.56B 2025-09
Avita Medical AUD 10.24M 1.98M 2025-12
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
IQVIA Holdings USD 1.95B 33M 2026-03
Lupin INR 30.4B 1.02B 2025-09
Moderna USD 1.91B 687M 2026-03
Organon & Co USD 1.12B 542M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Tilray USD 264.83M 43.16M 2025-06
Viatris USD 1.8B 481.8M 2026-03
Xeris Pharmaceuticals USD 111.75M 708K 2026-03